Pyoderma Gangrenosum

ByJulia Benedetti, MD, Harvard Medical School
Reviewed/Revised Apr 2022
View Patient Education

Pyoderma gangrenosum is a chronic, neutrophilic, progressive skin necrosis of unknown etiology often associated with systemic illness and sometimes skin injury. Diagnosis is clinical. Treatment includes wound care and, based on severity, anti-inflammatory drugs or immunosuppressants.

Etiology of Pyoderma Gangrenosum

Etiology of pyoderma gangrenosum is unknown, but it can be associated with various systemic illnesses, including inflammatory bowel disease, rheumatoid arthritis, cancers, and hematologic disorders (eg, monoclonal gammopathy of undetermined significance, myelodysplastic syndrome, polycythemia vera). It is thought to be mediated by an abnormal immune response. Most patients are age 25 to 55. It can manifest in various subtypes.

Pathophysiology of Pyoderma Gangrenosum

Pathophysiology of pyoderma gangrenosum is poorly understood but may involve problems with neutrophil chemotaxis. Interleukin-8 is overexpressed in lesions. Ulcerations of pyoderma gangrenosum occur after trauma or injury to the skin in about 30% of patients; this process is termed pathergy.

Symptoms and Signs of Pyoderma Gangrenosum

Most often, pyoderma gangrenosum begins as an inflamed erythematous papule, pustule, or nodule. The lesion, which may resemble a furuncle or an arthropod bite at this stage, ulcerates and expands rapidly, developing a swollen necrotic base and a raised dusky to violaceous border. An undermined border (ie, loss of underlying support tissue at the border) is common, if not pathognomonic. Systemic symptoms such as fever and malaise are common. The ulcers can coalesce to form larger ulcers, often with cribriform or sieve-like scarring.

Symptoms and signs can vary with the subtype.

Ulcerative (classic) subtype

In this most common subtype, ulcers form as described above, most commonly on the lower extremities or trunk, particularly the buttocks and perineum.

Pyoderma Gangrenosum Ulcerative (Classic) Subtype
Hide Details
This photo shows an ulcerated lesion with a necrotic base and raised dusky to violaceous border on the leg.
© Springer Science+Business Media

Bullous (atypical) subtype

This less common subtype often develops in patients with hematologic disorders. Lesions usually begin as bullae that erode, becoming superficial ulcers. The arms and face are most often involved.

Pyoderma Gangrenosum Bullous (Atypical) Subtype
Hide Details
This photo shows multiple eroded bullae forming superficial lesions on a patient's arm.
© Springer Science+Business Media

Pustular subtype

This subtype tends to develop during exacerbations of inflammatory bowel disease. Painful pustules develop, surrounded by erythema. Arthralgias are common.

Vegetative (superficial granulomatous pyoderma) subtype

In this subtype, a single, indolent, mildly painful plaque or superficial ulcer develops, most often on the head or neck. The border is not undermined and the base is not necrotic.

Pyoderma Gangrenosum Vegetative (Superficial Granulomatous Pyoderma)...
Hide Details
This photo shows a single superficial ulcer without raised borders or necrotic base.
© Springer Science+Business Media

Other subtypes

Pyoderma gangrenosum can also develop at other sites, such as around a stoma in patients who have inflammatory bowel disease (peristomal pyoderma gangrenosum), on the genitals (genital pyoderma gangrenosum), or in sites other than the skin, such as the bones, cornea, central nervous system, heart, intestine, liver, lungs, or muscle (extracutaneous pyoderma gangrenosum).

Diagnosis of Pyoderma Gangrenosum

  • Clinical evaluation

Diagnosis of pyoderma gangrenosum is clinical and is a diagnosis of exclusion after other causes of ulceration have been ruled out. Expansion of ulceration after surgical debridement strongly suggests pyoderma gangrenosum. Biopsies of lesions are not often diagnostic but may be supportive; 40% of biopsies from a leading edge show vasculitis with neutrophils and fibrin in superficial vessels.

Patients who have bullous (atypical) pyoderma gangrenosum should be monitored with periodic clinical assessment and complete blood count for development of a hematologic disorder.

Treatment of Pyoderma Gangrenosum

  • Wound care

  • Corticosteroids

  • Tumor necrosis factor (TNF)-alpha inhibitors

  • Sometimes other anti-inflammatory drugs or immunosuppressants

  • Avoidance of surgical debridement

inflammatory bowel disease

Surgical treatments are avoided because of the risk of wound extension (1).

Treatment reference

  1. 1. Alavi A, French LE, Davis MD, et al: Pyoderma gangrenosum: An update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol 18(3):355–372, 2017. doi: 10.1007/s40257-017-0251-7

Key Points

  • Pyoderma gangrenosum is often associated with a systemic disorder and is probably immune-mediated.

  • There are several subtypes; the ulcerative subtype (ie, necrotic base and raised violaceous border with undermined edge on a lower extremity, buttock, or perineum) is most common.

  • Diagnose pyoderma gangrenosum clinically.

  • Optimize wound care and avoid surgical debridement.

quizzes_lightbulb_red
Test your KnowledgeTake a Quiz!
Download the free MSD Manual App iOS ANDROID
Download the free MSD Manual App iOS ANDROID
Download the free MSD Manual App iOS ANDROID